Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colitis, Ulcerative × NX-13 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Colitis, Ulcerative 1

Interventions

pembrolizumab 1 peficitinib 1 Vitamin E 1 Specimen Handling 1 Nivolumab 1 NX-13 1 Methylprednisolone 1 Medical Marijuana 1 Iron-Dextran Complex 1 Colonoscopy 1 Biopsy 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05785715 2025-07-01

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

AbbVie

Phase 2 Terminated

Colitis, Ulcerative, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡